Pharmaxi LLC is a client-focused, adaptable, inventive, and cost-effective company that specializes in clinical trials (CRO). We provide clinical services for medicinal products, medical devices, and dietary supplements. We conduct clinical trials in Poland, Ukraine, and Eastern Europe. We understand that each project is unique, and as such, our core procedures are guided by a set of project documents that capture and monitor all the project-specific aspects of the clinical trial.
At Pharmaxi LLC, we specialize in the planning and management of clinical research projects that generate high-quality clinical evidence. We conduct clinical trials, clinical studies, post-marketing studies, and registries to collect clinical and performance data for medicines, medical devices, and IVD products. As a full-service CRO, Pharmaxi primarily supports small and medium-sized pharmaceutical, biotech, and medical device companies. Operating in Poland and across Eastern Europe, we deliver high-quality clinical trials tailored to the specific needs of our clients. Whether you are planning a clinical trial in Poland or elsewhere in Europe, our experienced team has the expertise and resources to support your project. If you are looking for a reliable contract research organization in Poland or beyond, please contact us.
As a mid-sized provider of clinical research services for biopharma and pharma sponsors, Pharmaxi supports healthcare programs focusing on Europe and the wider CEE region, as well as worldwide through partner networks. Our teams cover the full EU submission and delivery process, including pharmacovigilance support, and practical study pricing considerations—helping sponsors align regulatory expectations with real-world execution.
Nutrasource:
“I would like to extend my sincerest appreciation for the outstanding services rendered by
Pharmaxi LLC during our recent clinical research project, R10414.
Pharmaxi LLC has demonstrated exceptional commitment and resilience throughout the project in navigating logistical challenges and monitoring participant safety.
Their unwavering dedication to maintaining the highest service standards has significantly
contributed to the success of our project.
We are grateful for the partnership we have formed with Pharmaxi LLC and look forward to the
possibility of collaborating on future projects.”
William J Rowe, President and CEO
Immune Biosolutions:
“I am writing to express my sincere appreciation for the outstanding performance of Pharmaxi in conducting our recent Covid clinical trials. The trials were executed with utmost efficiency, adhering to both the designated timeline and the allocated budget.
Throughout the process, the responses from the clinical team were consistently timely and accurate. This level of commitment and professionalism significantly contributed to the success of the trials. The precision and swiftness with which Pharmaxi operated reflect their dedication to excellence in clinical research.
I would like to extend my gratitude to the entire team involved in these trials for their hard work and commitment to ensuring the study’s success. Their diligence and expertise have not only met but exceeded our expectations.
We look forward to the possibility of future collaboration with Pharmaxi based on this positive experience. Please convey our appreciation to the team for their exceptional efforts.
Thank you for your continued commitment to advancing medical research.”
Luc Paquet, CEO
Clinical Research Strategies:
“We enjoy working with our partners at Pharmaxi with their impressive and responsive team for drug and
device development, and CRO support. We highly endorse this company for their highest values and
standards.”
Alethea Wieland, President and Founder, USA
Sanofi:
“Pharmaxi LLC maintains the high professional level of personnel and clear processes aimed at
goals achievement. We recognize Pharmaxi LLC as a trustworthy partner with a responsible attitude
to their obligations and consider them to be a team of experts in the profile activity. We recommend
Pharmaxi LLC as a reliable and stable business partner.”
Alla Gontar, Medical Head
AbbVie:
“We’ve been working with Pharmaxi since 2014 in frame of epidemiological multicentre study in
Ukraine and the Baltic countries in the field of hepatitis C. We are satisfied with the work of the
team that demonstrates the high level of professionalism and quality in the design and management
of clinical databases.”
Galina Bryn, Ukraine & CIS Medical manager
A free 30-minutes consultation with our project managers, medical writers, data managers or regulatory experts.
You will get an efficient advice on how to elaborate your study design or clinical trials data collection approach and where to focus your efforts today.
No cost. No obligations.
Just come and find a solution.
Immediate advice provides from 9.00 to 18.00 (Polish time).
If time is up, please fill the form or leave your phone number and we will call you later.
